COCP
NASDAQ · Pharmaceuticals
Cocrystal Pharma Inc
$1.04
+0.04 (+4.00%)
Open$0.98
Previous Close$1.00
Day High$1.04
Day Low$0.98
52W High$2.03
52W Low$0.76
Volume—
Avg Volume30.9K
Market Cap19.07M
P/E Ratio—
EPS$-0.76
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,584.6% upside
Current
$1.04
$1.04
Target
$27.92
$27.92
$19.61
$27.92 avg
$38.36
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.74M | 2.80M | 3.00M |
| Net Income | 504.5K | 668.5K | 544.9K |
| Profit Margin | 18.4% | 23.9% | 18.1% |
| EBITDA | 921.2K | 997.7K | 969.2K |
| Free Cash Flow | 728.8K | 746.2K | 561.0K |
| Rev Growth | +19.3% | -9.2% | +14.0% |
| Debt/Equity | 0.92 | 0.92 | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |